BRISTOL-MYERS SQUIBB CO (1BMY.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1BMY - US1101221083 - Common Stock
39.635 EUR
-0.02 (-0.06%)
We assign a fundamental rating of 5 out of 10 to 1BMY. 1BMY was compared to 54 industry peers in the Pharmaceuticals industry. Both the profitability and the financial health of 1BMY get a neutral evaluation. Nothing too spectacular is happening here. 1BMY scores decently on growth, while it is valued quite cheap. This could make an interesting combination. 1BMY also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year 1BMY was profitable.
1BMY had a positive operating cash flow in the past year.
In multiple years 1BMY reported negative net income over the last 5 years.
1BMY had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of 1BMY (5.33%) is comparable to the rest of the industry.
With a decent Return On Equity value of 28.96%, 1BMY is doing good in the industry, outperforming 77.78% of the companies in the same industry.
The Return On Invested Capital of 1BMY (16.07%) is better than 79.63% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1BMY is below the industry average of 14.51%.
The 3 year average ROIC (11.67%) for 1BMY is below the current ROIC(16.07%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.33% | ||
| ROE | 28.96% | ||
| ROIC | 16.07% |
ROA(3y)1.77%
ROA(5y)0.82%
ROE(3y)-2.38%
ROE(5y)-2.3%
ROIC(3y)11.67%
ROIC(5y)9.83%
1.3 Margins
1BMY has a Profit Margin (10.58%) which is in line with its industry peers.
1BMY has a Operating Margin of 30.27%. This is in the better half of the industry: 1BMY outperforms 77.78% of its industry peers.
1BMY's Operating Margin has declined in the last couple of years.
1BMY has a Gross Margin of 73.92%. This is in the better half of the industry: 1BMY outperforms 62.96% of its industry peers.
1BMY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 30.27% | ||
| PM (TTM) | 10.58% | ||
| GM | 73.92% |
OM growth 3Y-0.56%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y1.42%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1BMY is creating value.
Compared to 1 year ago, 1BMY has less shares outstanding
1BMY has less shares outstanding than it did 5 years ago.
1BMY has a worse debt/assets ratio than last year.
2.2 Solvency
1BMY has an Altman-Z score of 2.03. This is not the best score and indicates that 1BMY is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.03, 1BMY is not doing good in the industry: 62.96% of the companies in the same industry are doing better.
The Debt to FCF ratio of 1BMY is 3.37, which is a good value as it means it would take 1BMY, 3.37 years of fcf income to pay off all of its debts.
1BMY has a Debt to FCF ratio (3.37) which is comparable to the rest of the industry.
A Debt/Equity ratio of 2.56 is on the high side and indicates that 1BMY has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.56, 1BMY is doing worse than 79.63% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.56 | ||
| Debt/FCF | 3.37 | ||
| Altman-Z | 2.03 |
ROIC/WACC2.06
WACC7.8%
2.3 Liquidity
1BMY has a Current Ratio of 1.21. This is a normal value and indicates that 1BMY is financially healthy and should not expect problems in meeting its short term obligations.
1BMY has a Current ratio of 1.21. This is comparable to the rest of the industry: 1BMY outperforms 40.74% of its industry peers.
A Quick Ratio of 1.11 indicates that 1BMY should not have too much problems paying its short term obligations.
1BMY's Quick ratio of 1.11 is fine compared to the rest of the industry. 1BMY outperforms 74.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.11 |
3. Growth
3.1 Past
1BMY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 391.24%, which is quite impressive.
1BMY shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -24.57% yearly.
1BMY shows a small growth in Revenue. In the last year, the Revenue has grown by 2.57%.
1BMY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.06% yearly.
EPS 1Y (TTM)391.24%
EPS 3Y-46.63%
EPS 5Y-24.57%
EPS Q2Q%-29.47%
Revenue 1Y (TTM)2.57%
Revenue growth 3Y1.36%
Revenue growth 5Y13.06%
Sales Q2Q%0.56%
3.2 Future
The Earnings Per Share is expected to grow by 36.11% on average over the next years. This is a very strong growth
Based on estimates for the next years, 1BMY will show a decrease in Revenue. The Revenue will decrease by -4.99% on average per year.
EPS Next Y477.64%
EPS Next 2Y131.04%
EPS Next 3Y73.61%
EPS Next 5Y36.11%
Revenue Next Year-1.12%
Revenue Next 2Y-4.71%
Revenue Next 3Y-3.48%
Revenue Next 5Y-4.99%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
1BMY is valuated cheaply with a Price/Earnings ratio of 6.88.
Based on the Price/Earnings ratio, 1BMY is valued cheaply inside the industry as 92.59% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of 1BMY to the average of the S&P500 Index (25.45), we can say 1BMY is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 7.61, the valuation of 1BMY can be described as very cheap.
1BMY's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1BMY is cheaper than 90.74% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of 1BMY to the average of the S&P500 Index (34.46), we can say 1BMY is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.88 | ||
| Fwd PE | 7.61 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1BMY indicates a rather cheap valuation: 1BMY is cheaper than 88.89% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, 1BMY is valued cheaper than 94.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.46 | ||
| EV/EBITDA | 6 |
4.3 Compensation for Growth
1BMY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as 1BMY's earnings are expected to grow with 73.61% in the coming years.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y131.04%
EPS Next 3Y73.61%
5. Dividend
5.1 Amount
1BMY has a Yearly Dividend Yield of 5.72%, which is a nice return.
1BMY's Dividend Yield is rather good when compared to the industry average which is at 3.01. 1BMY pays more dividend than 92.59% of the companies in the same industry.
1BMY's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.72% |
5.2 History
The dividend of 1BMY is nicely growing with an annual growth rate of 11.67%!
Dividend Growth(5Y)11.67%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1BMY pays out 98.12% of its income as dividend. This is not a sustainable payout ratio.
1BMY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP98.12%
EPS Next 2Y131.04%
EPS Next 3Y73.61%
BIT:1BMY (11/20/2025, 7:00:00 PM)
39.635
-0.02 (-0.06%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners82.84%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap80.67B
Revenue(TTM)47.70B
Net Income(TTM)5.05B
Analysts67.27
Price Target44.38 (11.97%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.72% |
Yearly Dividend2.07
Dividend Growth(5Y)11.67%
DP98.12%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.2%
Min EPS beat(2)19.36%
Max EPS beat(2)35.04%
EPS beat(4)4
Avg EPS beat(4)21.86%
Min EPS beat(4)13.54%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)17.22%
EPS beat(12)11
Avg EPS beat(12)11.73%
EPS beat(16)15
Avg EPS beat(16)9.9%
Revenue beat(2)2
Avg Revenue beat(2)5.24%
Min Revenue beat(2)3.68%
Max Revenue beat(2)6.79%
Revenue beat(4)4
Avg Revenue beat(4)5.13%
Min Revenue beat(4)3.68%
Max Revenue beat(4)6.79%
Revenue beat(8)7
Avg Revenue beat(8)3.53%
Revenue beat(12)8
Avg Revenue beat(12)1.72%
Revenue beat(16)10
Avg Revenue beat(16)1.44%
PT rev (1m)-3.96%
PT rev (3m)-9.57%
EPS NQ rev (1m)-5.08%
EPS NQ rev (3m)-7.02%
EPS NY rev (1m)0.08%
EPS NY rev (3m)-5.25%
Revenue NQ rev (1m)0.29%
Revenue NQ rev (3m)1.21%
Revenue NY rev (1m)0.15%
Revenue NY rev (3m)2.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.88 | ||
| Fwd PE | 7.61 | ||
| P/S | 1.98 | ||
| P/FCF | 6.46 | ||
| P/OCF | 5.93 | ||
| P/B | 5.4 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6 |
EPS(TTM)5.76
EY14.53%
EPS(NY)5.21
Fwd EY13.14%
FCF(TTM)6.13
FCFY15.47%
OCF(TTM)6.69
OCFY16.87%
SpS20.06
BVpS7.33
TBVpS-10.82
PEG (NY)0.01
PEG (5Y)N/A
Graham Number30.83
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.33% | ||
| ROE | 28.96% | ||
| ROCE | 21.51% | ||
| ROIC | 16.07% | ||
| ROICexc | 20.14% | ||
| ROICexgc | 101.89% | ||
| OM | 30.27% | ||
| PM (TTM) | 10.58% | ||
| GM | 73.92% | ||
| FCFM | 30.56% |
ROA(3y)1.77%
ROA(5y)0.82%
ROE(3y)-2.38%
ROE(5y)-2.3%
ROIC(3y)11.67%
ROIC(5y)9.83%
ROICexc(3y)13.73%
ROICexc(5y)11.71%
ROICexgc(3y)74.95%
ROICexgc(5y)76.74%
ROCE(3y)15.62%
ROCE(5y)13.15%
ROICexgc growth 3Y-16.88%
ROICexgc growth 5Y3.18%
ROICexc growth 3Y7.41%
ROICexc growth 5Y19.82%
OM growth 3Y-0.56%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y1.42%
F-Score7
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.56 | ||
| Debt/FCF | 3.37 | ||
| Debt/EBITDA | 2.14 | ||
| Cap/Depr | 20.37% | ||
| Cap/Sales | 2.77% | ||
| Interest Coverage | 6.99 | ||
| Cash Conversion | 75.95% | ||
| Profit Quality | 288.73% | ||
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.11 | ||
| Altman-Z | 2.03 |
F-Score7
WACC7.8%
ROIC/WACC2.06
Cap/Depr(3y)12.09%
Cap/Depr(5y)10.53%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)391.24%
EPS 3Y-46.63%
EPS 5Y-24.57%
EPS Q2Q%-29.47%
EPS Next Y477.64%
EPS Next 2Y131.04%
EPS Next 3Y73.61%
EPS Next 5Y36.11%
Revenue 1Y (TTM)2.57%
Revenue growth 3Y1.36%
Revenue growth 5Y13.06%
Sales Q2Q%0.56%
Revenue Next Year-1.12%
Revenue Next 2Y-4.71%
Revenue Next 3Y-3.48%
Revenue Next 5Y-4.99%
EBIT growth 1Y30.41%
EBIT growth 3Y0.79%
EBIT growth 5Y8.21%
EBIT Next Year263.82%
EBIT Next 3Y49.42%
EBIT Next 5Y23.71%
FCF growth 1Y35.99%
FCF growth 3Y-2.91%
FCF growth 5Y14.03%
OCF growth 1Y34.19%
OCF growth 3Y-2.14%
OCF growth 5Y13.49%
BRISTOL-MYERS SQUIBB CO / 1BMY.MI FAQ
Can you provide the ChartMill fundamental rating for BRISTOL-MYERS SQUIBB CO?
ChartMill assigns a fundamental rating of 5 / 10 to 1BMY.MI.
What is the valuation status of BRISTOL-MYERS SQUIBB CO (1BMY.MI) stock?
ChartMill assigns a valuation rating of 9 / 10 to BRISTOL-MYERS SQUIBB CO (1BMY.MI). This can be considered as Undervalued.
Can you provide the profitability details for BRISTOL-MYERS SQUIBB CO?
BRISTOL-MYERS SQUIBB CO (1BMY.MI) has a profitability rating of 5 / 10.
What is the financial health of BRISTOL-MYERS SQUIBB CO (1BMY.MI) stock?
The financial health rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 4 / 10.
How sustainable is the dividend of BRISTOL-MYERS SQUIBB CO (1BMY.MI) stock?
The dividend rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 7 / 10 and the dividend payout ratio is 98.12%.